BIODESIX INC (BDSX)
US09075X1081 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to BDSX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.16. This target is 163.5% above the current price.
BDSX was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BDSX.
In the previous month the buy percentage consensus was at a similar level.
BDSX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-07-26 | Craig-Hallum | Initiate | Buy |
| 2024-05-13 | TD Cowen | Initiate | Buy |
| 2024-05-03 | Lake Street | Initiate | Buy |
| 2024-03-04 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-12-07 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2022-05-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-20 | Cowen & Co. | Initiate | Outperform |
| 2021-11-17 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-05-12 | Morgan Stanley | Maintains | Overweight |
| 2021-03-18 | Morgan Stanley | Maintains | Overweight |